ImmunityBio, Inc. (IBRX)

9.715 +1.02 (+11.67%) USD  |  NASDAQ  |  Feb 23, 14:19
More

ImmunityBio Ending Cash (Quarterly)

Ending Cash (Quarterly) Chart

View Ending Cash (Quarterly) for IBRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Ending Cash (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Ending Cash (Quarterly) Range, Past 5 Years

View Ending Cash (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Ending Cash (Quarterly) Benchmarks

View Ending Cash (Quarterly) Benchmarks
Start Trial
Novavax, Inc. Upgrade
Krystal Biotech, Inc. Upgrade
Rapt Therapeutics, Inc. Upgrade
Moderna, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade